Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Claris Lifesciences Limited
WARNING LETTER
•Claris Lifesciences Limited•June 16, 2010

Claris Lifesciences Limited – FDA Warning Letter, Jun 16, 2010

Record Details

The FDA issued a Warning Letter to Claris Lifesciences Limited (Claris India) and its subsidiary Claris Lifesciences, Inc. (Claris U.S.) following inspections in June 2010 (Claris India), July 2009, and January/February 2010 (Claris U.S.). The inspections revealed significant violations of Current Good Manufacturing Practice (CGMP) regulations (21 CFR Parts 210 and 211), rendering drug products adulterated under 21 U.S.C. § 351(a)(2)(B).

Key violations include: 1. **Inadequate Complaint Investigations (21 CFR § 211.192):** Failure to thoroughly investigate contamination complaints for Metronidazole Injection USP and Ondansetron Injection USP IV bags, lacking scientific justification for root causes (e.g., defective printing stereos, packaging issues) and failing to promptly notify all affected customers. 2. **Insufficient Production and Process Controls (21 CFR § 211.100(a)):** Lack of procedures to evaluate in-process units rejected due to defects, with no documented investigations for significant deviations. 3. **Inadequate Equipment Design and Calibration (21 CFR § 211.63):** Thermocouples used for terminal sterilizer validation were not calibrated before or after cycles, lacking data to support

Company
Claris Lifesciences Limited
Inspection date
June 16, 2010
Product type
Drugs
Office
Center for Drug Evaluation and Research
People
  • Deborah M. Autor (Former FDA Deputy Commissioner)
  • A Menon
View Company Profile

ID · 2b76cc1e-a224-42c2-b8e5-e152c8558775

Violation Codes10
21 CFR 21021 CFR 21121 U.S.C. 355(k)21 CFR 314.81(b)(1)(ii)21 U.S.C. 331(d)21.U.S.C. 355(a)21 U.S.C. 352(f)(1)FD&C Act 801(a)(3)21 U.S.C. 381(a)(3)21 U.S.C. 321(g)(1)(B)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Claris Lifesciences Limited
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.